Prokopenko I, Langenberg C, Florez JC, et al. (January 2009). „Variants in MTNR1B influence fasting glucose levels”. Nat. Genet.41 (1): 77–81. DOI:10.1038/ng.290. PMC2682768. PMID19060907.; Lyssenko V, Nagorny CL, Erdos MR, et al. (January 2009). „Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion”. Nat. Genet.41 (1): 82–8. DOI:10.1038/ng.288. PMID19060908.; Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. (January 2009). „A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk”. Nat. Genet.41 (1): 89–94. DOI:10.1038/ng.277. PMID19060909.
Rivara S, Lodola A, Mor M, et al. (2007). „N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands”. J. Med. Chem.50 (26): 6618–26. DOI:10.1021/jm700957j. PMID18052314.
Bedini A, Spadoni G, Gatti G, et al. (2006). „Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands”. J. Med. Chem.49 (25): 7393–403. DOI:10.1021/jm060850a. PMID17149869.
Prokopenko I, Langenberg C, Florez JC, et al. (January 2009). „Variants in MTNR1B influence fasting glucose levels”. Nat. Genet.41 (1): 77–81. DOI:10.1038/ng.290. PMC2682768. PMID19060907.; Lyssenko V, Nagorny CL, Erdos MR, et al. (January 2009). „Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion”. Nat. Genet.41 (1): 82–8. DOI:10.1038/ng.288. PMID19060908.; Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. (January 2009). „A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk”. Nat. Genet.41 (1): 89–94. DOI:10.1038/ng.277. PMID19060909.
Rivara S, Lodola A, Mor M, et al. (2007). „N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands”. J. Med. Chem.50 (26): 6618–26. DOI:10.1021/jm700957j. PMID18052314.
Bedini A, Spadoni G, Gatti G, et al. (2006). „Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands”. J. Med. Chem.49 (25): 7393–403. DOI:10.1021/jm060850a. PMID17149869.